Last updated 2026-08-21
- Raised $655k Series A led by Garage+, Oct 2023
- Raised $500k Seed round led by Y Combinator, Jun 2022
- Raised Series B, Nov 2024
Total raised
$1.2M
Stage
—
Founded
2022
Headcount
—
HQ
New York, United States
Sector
Biotech
About
Serinus Biosciences is an AI drug discovery company focused on creating combination therapies to overcome cancer treatment resistance. They leverage a knowledge-primed AI engine that integrates computational biology and functional genomics to understand the molecular landscape of treatment response and resistance. The company aims to develop drugs that are effective across various patient populations, override resistance mechanisms, and enable combinations by design.
Funding history · 3 rounds · $1.2M total
3 events/rounds · $1.2M Total Funding: $1.2M in Private Equity
Nov 2024
B Round
Undisclosed
pitchbook.com
Oct 2023
A Round
$655K
pitchbook.com
★ Garage+★ Good Ventures★ Sunstone Management★ Taiwan Global Angels★ Berkeley SkyDeck Fund
Jun 2022
★ Y Combinator★ Merck Digital Sciences StudioVertex Ventures2 more investorsIllumina VenturesEndless Frontier LabsSapir Venture PartnersAlexandria Real Estate Equities
Offices
New York, United States · HQ / main office
Q&A
- What is Serinus Biosciences Inc.'s primary focus?
- Serinus Biosciences Inc. is an AI drug discovery company focused on creating combination therapies to overcome cancer treatment resistance.
- What technology does Serinus Biosciences Inc. leverage for drug discovery?
- Serinus Biosciences Inc. leverages a knowledge-primed AI engine that integrates computational biology and functional genomics to understand the molecular landscape of treatment response and resistance.
- When was Serinus Biosciences Inc. founded?
- Serinus Biosciences Inc. was founded in 2022.
- Where is Serinus Biosciences Inc. headquartered?
- Serinus Biosciences Inc. is headquartered in New York, United States.
- Who are the founders of Serinus Biosciences Inc.?
- The founders of Serinus Biosciences Inc. are Adam Yaari, who serves as Founder/CEO, and Maxwell Sherman.
- What are the target markets for Serinus Biosciences Inc.'s technology?
- Serinus Biosciences Inc. targets the Cancer Treatment and Drug Discovery markets.
- What is Serinus Biosciences Inc.'s primary sector?
- Serinus Biosciences Inc.'s primary sector is Biotech.
Sectors & technology
Primary sector
Biotech
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | serinus.bio |
|---|
Identifiers & details
| Founded | 2022 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | serinus.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|